Quarterlytics / Healthcare / Biotechnology / Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

ALDX · NASDAQ Healthcare

Claim this profile

Ticker ALDX

Exchange NASDAQ

Sector Healthcare

Industry Biotechnology

Employees 9

Overview Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management

Company Profile

Aldeyra Therapeutics: Can a RASP-Based Ocular Strategy Bridge the Gap to Revenue?

When Aldeyra Therapeutics won FDA acceptance for two eye-disease drug applications on the same March 2023 day, management framed the event as validation of a lo…

ALDX Jun 19, 2026